The congress is a global interactive event that aims to promote cardiovascular health by uniting cardiovascular disease specialists with other disciplines to network, share knowledge and build innovative solutions for patients and populations.
Around 4,000 participants representing international organisations and bodies from around the world (such as the World Health Organisation, the European Society of Cardiology, American Heart Association, American College of Cardiology, African Heart Network, and Saudi Heart Association) are expected to attend the congress.
The congress's agenda includes more than 200 scientific sessions on cardiovascular disease and related diseases such as high cholesterol. Six hundred specialists are expected to take part in the conference where 1,000 scientific papers about the latest achievements and challenges in the field will be shared.
The World Congress of Cardiology & Cardiovascular Health 2018 will also provide an interactive programme designed to respond to the needs of professionals.
Cardiovascular disease is the number one cause of death across the world. According to some studies, heart attacks take place approximately ten years earlier in the Middle East than in many Western countries.
The cardiology department is the second-busiest unit in Rashid Hospital after the Emergency and Trauma Centre.
Dr Fahad Baslaib, Consultant Cardiology, CEO of Rashid Hospital and congress president said winning the bid to host such an international congress reflects the medical achievements made by the DHA especially in cardiology and cardiovascular health, which are considered the leading cause of death worldwide.
Dr Baslaib emphasised that the congress, which is considered the biggest event specialising in cardiology and cardiovascular health due to the international caliber of specialist attending, provides an ideal platform for decision makers in the health field to discuss how to achieve the objective set by the World Health Organisation to reduce the global rate of heart attacks by 2025.
For further information, please contact:
Mahmoud Al Ali
Head of Media
Dubai Health Authority
+9714 219 7260
Kamakshi Gupta and Noor Nazzal
Communications Analysts- Media Dept.
Dubai Health Authority
About the Dubai Health Authority:
The Dubai Health Authority (DHA) was created, in June 2007, by Law 13 issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE, Ruler of Dubai, with an expanded vision to include strategic oversight for the complete health sector in Dubai and enhance private sector engagement.
Prior to the establishment of the DHA, the Department of Health and Medical Services, which was established in 1973, was the functioning authority that almost exclusively focused on health service delivery.
In May 2018, H.H Sheikh Mohammed, issued Law No. (6) Of 2018 of the DHA. The new Law further enables the DHA to achieve its objectives including regulating medical services in Dubai, enhancing competiveness and transparency, improving medical services and products based on international best practices and achieving the sector’s objectives according to approved strategic plans.
According to the Law, DHA will ensure the availability of quality medical insurance programmes, improve medical services according to the highest international standards, contribute to providing attractive infrastructure for investments, boost Dubai’s position as a global hub for medical tourism and medical education, encourage innovation in the healthcare sector and improve preventive healthcare measures.
The Law specified DHA’s responsibilities to include preparing a comprehensive strategic plan for Dubai’s healthcare sector, conducting studies and surveys to define Dubai’s future needs and matching the results with future investments, licensing and monitoring medical workers and medical facilities according to DHA’s approved regulations. Its responsibilities also include regulating medical education and medical research in collaboration with competent local and international authorities and drafting and developing policies and procedures for the healthcare sector in Dubai.
The Law authorises DHA to regulate and approve the prices of medical services offered by private healthcare facilities in Dubai and ensure the quality of medical services. DHA is also responsible for regulating and facilitating the sending of patients for specialised medical treatment to healthcare facilities both within and outside the country, regulating and overseeing medical tourism in collaboration with concerned authorities, managing and developing policies that govern medical insurance and regulating medical advertising in Dubai.
H.H Sheikh Mohammed also issued Decree No. 17 of 2018 establishing subsidiaries of the DHA: the Dubai Healthcare Corporation and Dubai Health Insurance Corporation to further enhance healthcare services in Dubai and enable DHA to fulfil its responsibilities and obligations.
Three new strategic sectors were also added as part of the decree; they include Strategy and Corporate Development, Health Regulation, and Shared Support Services.
In addition to overseeing the health sector for the Emirate of Dubai, the DHA also focuses on providing services through DHA healthcare facilities including Latifa, Dubai, Rashid and Hatta Hospitals, its 12 primary healthcare centres, 17 medical fitness centres and its 6 specialty centres.
For more information, visit DHA’s website: www.dha.gov.ae
© Press Release 2018